Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Product defect recall alert
Huvepharma N.V have contacted wholesale dealers and veterinary surgeons to examine inventory immediately.

Gallifen 200 mg/ml Suspension and Pigfen 200 mg/ml Suspension.

The Veterinary Medicines Directorate (VMD) has issued a product defect recall alert for two products manufactured by Huvepharma N.V.

The recall affects the following finished products from the UK market:

  • two batches of Gallifen 200 mg/ml Suspension for Use in Drinking Water for Chickens and Pheasants
  • six batches of Pigfen 200 mg/ml Suspension for Use in Drinking Water for Pigs.

The VMD writes: 'Fenbendazole content has been found lower than the agreed specification limit and sediment/caking layer is present on bottom of the bottle...Huvepharma N.V have contacted wholesale dealers and veterinary surgeons to examine inventory immediately and quarantine products subject to this recall.'

The recall affects the following batches only:
 

Product
Batch No.
Expiry date
Gallifen 200mg/ml 19041748008 31/10/2021
Gallifen 200mg/ml 19091748023 30/03/2022
Pigfen 200mg/ml 18061747014 31/12/2020
Pigfen 200mg/ml 18091747020 30/03/2021
Pigfen 200mg/ml 19011747001 31/07/2021
Pigfen 200mg/ml 19031747019 30/09/2021


Further details can be obtained from Laura Kappelle Laura.Kappelle@huvepharma.com

 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.